Skip to main content
Have a personal or library account? Click to login
Association Between Myocardial Infarction and Triglyceride-Glucose Index: A Study Based on NHANES Database Cover

Association Between Myocardial Infarction and Triglyceride-Glucose Index: A Study Based on NHANES Database

By: Dandan Zheng and  Ligong Cao  
Open Access
|Feb 2024

References

  1. Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019; 74: 252932. DOI: 10.1016/j.jacc.2019.10.009
  2. Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: A compass for global action. J Am Coll Cardiol. 2020; 76: 29801. DOI: 10.1016/j.jacc.2020.11.021
  3. Wen H, Niu X, Hu L, Sun N, Zhao R, Wang Q, et al. Dietary copper intake and risk of myocardial infarction in US adults: A propensity score-matched analysis. Front Cardiovasc Med. 2022; 9: 942000. DOI: 10.3389/fcvm.2022.942000
  4. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018; 72: 223164. DOI: 10.1016/j.jacc.2018.08.1038
  5. Lu Q, Liu P, Huo JH, Wang YN, Ma AQ, Yuan ZY, et al. Cardiac rupture complicating acute myocardial infarction: The clinical features from an observational study and animal experiment. BMC Cardiovasc Disord. 2020; 20: 409. DOI: 10.1186/s12872-020-01683-y
  6. Thomas KL, Velazquez EJ. Therapies to prevent heart failure post-myocardial infarction. Curr Heart Fail Rep. 2005; 2:17482. DOI: 10.1007/BF02696647
  7. Singam NSV, Tabi M, Wiley B, Anavekar N, Jentzer J. Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure. Int J Cardiol. 2023; 384: 3847. DOI: 10.1016/j.ijcard.2023.04.041
  8. Garcia R, Marijon E, Karam N, Narayanan K, Anselme F, Cesari O, et al. Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study. Eur Heart J. 2022; 43: 488796. DOI: 10.1093/eurheartj/ehac579
  9. Nedkoff L, Briffa T, Murray K, Gaw J, Yates A, Sanfilippo FM, et al. Risk of early recurrence and mortality in high-risk myocardial infarction patients: A population-based linked data study. Int J Cardiol Cardiovasc Risk Prev. 2023; 17: 200185. DOI: 10.1016/j.ijcrp.2023.200185
  10. Nascimento BR, Brant LCC, Marino BCA, Passaglia LG, Ribeiro ALP. Implementing myocardial infarction systems of care in low/middle-income countries. Heart. 2019; 105: 206. DOI: 10.1136/heartjnl-2018-313398
  11. Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC, Hayman LL, et al. Value of primordial and primary prevention for cardiovascular disease: A policy statement from the American Heart Association. Circulation. 2011; 124: 96790. DOI: 10.1161/CIR.0b013e3182285a81
  12. Nystrom A, Stromberg S, Jansson K, Faresjo AO, Faresjo T. Cardiovascular risks before myocardial infarction differences between men and women. BMC Cardiovasc Disord. 2022; 22: 110. DOI: 10.1186/s12872-022-02555-3
  13. Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease’ risk factors. Curr Cardiol Rev. 2018; 14: 15363. DOI: 10.2174/1573403X14666180222102312
  14. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 395: 795808. DOI: 10.1016/S0140-6736(19)32008-2
  15. Xiong S, Chen Q, Long Y, Su H, Luo Y, Liu H, et al. Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome. Cardiovasc Diabetol. 2023; 22: 56. DOI: 10.1186/s12933-023-01780-0
  16. Mone P, Lombardi A, Salemme L, Cioppa A, Popusoi G, Varzideh F, et al. Stress hyperglycemia drives the risk of hospitalization for chest pain in patients with ischemia and nonobstructive coronary arteries (INOCA). Diabetes Care. 2023; 46: 4504. DOI: 10.2337/dc22-0783
  17. Al-Ali SA, Alidrisi HA, Hameed A. Correlation of insulin resistance with short-term outcome in nondiabetic patients with ST-Segment Elevation Myocardial Infarction. Cureus. 2022; 14: e33093. DOI: 10.7759/cureus.33093
  18. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review. International journal of endocrinology. 2020; 2020: 4678526. DOI: 10.1155/2020/4678526
  19. Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021; 20: 113. DOI: 10.1186/s12933-021-01305-7
  20. Hao Q, Yuanyuan Z, Lijuan C. The prognostic value of the triglyceride glucose index in patients with acute myocardial infarction. J Cardiovasc Pharmacol Ther. 2023; 28:10742484231181846. DOI: 10.1177/10742484231181846
  21. Cheng W, Li M, Zhang L, Zhou C, Zhang X, Zhu C, et al. Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018. Ann Med. 2023; 55: 2216943. DOI: 10.1080/07853890.2023.2216943
  22. Zhang HR, Tian W, Qi G, Sun YJ. Combined association of dietary fibre and cognitive function with all-cause and cause-specific mortality in older adults. Ann Med. 2023; 55: 2221036. DOI: 10.1080/07853890.2023.2221036
  23. Zhao J, Fu S, Chen Q. Association between the serum vitamin D level and prevalence of obesity/abdominal obesity in women with infertility: A cross-sectional study of the National Health and Nutrition Examination Survey data. Gynecol Endocrinol. 2023; 39: 2217251. DOI: 10.1080/09513590.2023.2217251
  24. Liu XC, He GD, Lo K, Huang YQ, Feng YQ. The Triglyceride-Glucose Index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2020; 7: 628109. DOI: 10.3389/fcvm.2020.628109
  25. Shi YY, Zheng R, Cai JJ, Qian SZ. The association between triglyceride glucose index and depression: data from NHANES 2005–2018. BMC Psychiatry. 2021; 21: 267. DOI: 10.1186/s12888-021-03275-2
  26. Raimi TH, Dele-Ojo BF, Dada SA, Fadare JO, Ajayi DD, Ajayi EA, et al. Triglyceride-Glucose Index and related parameters predicted metabolic syndrome in Nigerians. Metabolic Syndrome and Related Disorders. 2021; 19: 7682. DOI: 10.1089/met.2020.0092
  27. Hu Z, Li Y, Yang Y, Yu W, Xie W, Song G, et al. Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: A population-based study. Sci Total Environ. 2021; 780: 146563. DOI: 10.1016/j.scitotenv.2021.146563
  28. Tian X, Xue B, Wang B, Lei R, Shan X, Niu J, et al. Physical activity reduces the role of blood cadmium on depression: A cross-sectional analysis with NHANES data. Environ Pollut. 2022; 304: 119211. DOI: 10.1016/j.envpol.2022.119211
  29. Patel U, Patel N, Khurana M, Parulekar A, Patel A, Ortiz JF, et al. Effect comparison of E-Cigarette and traditional smoking and association with stroke-A cross-sectional study of NHANES. Neurol Int. 2022; 14: 44152. DOI: 10.3390/neurolint14020037
  30. Liu Y, Geng T, Wan Z, Lu Q, Zhang X, Qiu Z, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with Type 2 diabetes. JAMA Netw Open. 2022; 5: e2146124. DOI: 10.1001/jamanetworkopen.2021.46124
  31. Dirisanala S, Laller S, Ganti N, Taj S, Patel N, Singh Arora K, et al. E-cigarette use and prevalence of lung diseases among the U.S. population: a NHANES survey. J Investig Med. 2023; 71: 61322. DOI: 10.1177/10815589231167357
  32. Zhang Y, Liu W, Zhang W, Cheng R, Tan A, Shen S, et al. Association between blood lead levels and hyperlipidemiais: Results from the NHANES (1999–2018). Front Public Health. 2022; 10: 981749. DOI: 10.3389/fpubh.2022.981749
  33. Cai XL, Xiang YF, Chen XF, Lin XQ, Lin BT, Zhou GY, et al. Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk. Cardiovasc Diabetol. 2023; 22: 198. DOI: 10.1186/s12933-023-01924-2
  34. Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, et al. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023; 22: 170. DOI: 10.1186/s12933-023-01906-4
  35. Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovascular Diabetology. 2018; 17: 41. DOI: 10.1186/s12933-018-0692-1
  36. Li M, Zhan A, Huang X, Hu L, Zhou W, Wang T, et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: The China H-Type Hypertension Registry study. Cardiovascular Diabetology. 2020; 19: 139. DOI: 10.1186/s12933-020-01124-2
  37. Nakagomi A, Sunami Y, Kawasaki Y, Fujisawa T, Kobayashi Y. Sex difference in the association between surrogate markers of insulin resistance and arterial stiffness. Journal of Diabetes and its Complications. 2020; 34: 107442. DOI: 10.1016/j.jdiacomp.2019.107442
  38. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362:215565. DOI: 10.1056/NEJMoa0908610
  39. Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: An 11-year prospective study in the Kailuan cohort. Cardiovascular Diabetology. 2021; 20: 19. DOI: 10.1186/s12933-020-01210-5
  40. Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World Journal of Diabetes. 2010; 1: 3647. DOI: 10.4239/wjd.v1.i2.36
  41. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic Syndrome and Related Disorders. 2008; 6: 299304. DOI: 10.1089/met.2008.0034
  42. Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. European Journal of Clinical Investigation. 2016; 46: 18997. DOI: 10.1111/eci.12583
  43. Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. The Journal of clinical endocrinology and metabolism. 2010; 95: 334751. DOI: 10.1210/jc.2010-0288
  44. Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovascular Diabetology. 2014; 13: 146. DOI: 10.1186/s12933-014-0146-3
  45. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetology. 2018; 17: 122. DOI: 10.1186/s12933-018-0762-4
  46. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 1998; 47: 2705. DOI: 10.2337/diab.47.2.270
  47. Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: A meta-analysis of cohort studies. Cardiovasc Diabetol. 2021; 20: 76. DOI: 10.1186/s12933-021-01268-9
  48. Lundqvist MH, Pereira MJ, Eriksson JW. Glucose-dependent inflammatory responses in obese compared to lean individuals. Endocrine. 2023; 81: 46476. DOI: 10.1007/s12020-023-03433-4
  49. Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2019; 234: 815261. DOI: 10.1002/jcp.27603
  50. Barazzoni R, Gortan Cappellari G, Ragni M, Nisoli E. Insulin resistance in obesity: An overview of fundamental alterations. Eat Weight Disord. 2018; 23: 14957. DOI: 10.1007/s40519-018-0481-6
  51. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018; 17: 122. DOI: 10.1186/s12933-018-0762-4
  52. Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119: 154766. DOI: 10.1016/j.metabol.2021.154766
  53. Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023; 22: 10. DOI: 10.1186/s12933-023-01737-3
  54. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140: e563e95. DOI: 10.1161/CIR.0000000000000724
  55. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42: 3227337. DOI: 10.1093/eurheartj/ehab484
  56. Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, et al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. Journal Of Translational Medicine. 2016; 14: 260. DOI: 10.1186/s12967-016-1020-8
  57. Xu H, Short SE, Liu T. Dynamic relations between fast-food restaurant and body weight status: a longitudinal and multilevel analysis of Chinese adults. Journal Of Epidemiology And Community Health. 2013; 67: 2719. DOI: 10.1136/jech-2012-201157
  58. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364: 93752. DOI: 10.1016/S0140-6736(04)17018-9
  59. Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB, et al. Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among peruvian adults. International Journal of Hypertension. 2011; 2011: 931402. DOI: 10.4061/2011/931402
  60. Sanlialp SC. Points to be resolved regarding the use of the triglyceride glucose index for cardiovascular disease. Angiology. 2021; 72: 10012. DOI: 10.1177/00033197211028429
  61. Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007–2010 Korean National Health and Nutrition Examination Survey. PloS one. 2019; 14: e0212963. DOI: 10.1371/journal.pone.0212963
  62. Aguirre MA, Jones CN, Pei D, Villa ML, Reaven GM. Ethnic differences in insulin resistance and its consequences in older Mexican American and non-Hispanic white women. J Gerontol A Biol Sci Med Sci. 1997; 52: M5660. DOI: 10.1093/gerona/52A.1.M56
  63. Hoffman RP, Copenhaver MM, Zhou D, Yu CY. Increased body fat and reduced insulin sensitivity are associated with impaired endothelial function and subendocardial viability in healthy, non-Hispanic white adolescents. Pediatr Diabetes. 2019; 20: 8428. DOI: 10.1111/pedi.12896
  64. Williams SK, Fiscella K, Winters P, Martins D, Ogedegbe G. Association of racial disparities in the prevalence of insulin resistance with racial disparities in vitamin D levels: National Health and Nutrition Examination Survey (2001–2006). Nutr Res. 2013; 33: 26671. DOI: 10.1016/j.nutres.2013.02.002
  65. He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. trends in cardiovascular risk factors in us adults by race and ethnicity and socioeconomic status, 1999–2018. JAMA. 2021; 326: 128698. DOI: 10.1001/jama.2021.15187
  66. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. heart disease and stroke statistics-2021 update: A report from the american heart association. Circulation. 2021; 143: e254e743.
  67. Brothers RM, Fadel PJ, Keller DM. Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction. Am J Physiol Heart Circ Physiol. 2019; 317: H777H89. DOI: 10.1152/ajpheart.00126.2019
  68. Baffi CW, Wood L, Winnica D, Strollo PJ Jr., Gladwin MT, Que LG, et al. Metabolic syndrome and the lung. Chest. 2016; 149: 152534. DOI: 10.1016/j.chest.2015.12.034
  69. Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, et al. Metabolic disorders in chronic lung diseases. Front Med (Lausanne). 2017; 4: 246. DOI: 10.3389/fmed.2017.00246
  70. Nie Z, Jacoby DB, Fryer AD. Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. Am J Respir Cell Mol Biol. 2014; 51: 25161. DOI: 10.1165/rcmb.2013-0452OC
  71. Lee H, Kim SR, Oh Y, Cho SH, Schleimer RP, Lee YC. Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma. Am J Respir Cell Mol Biol. 2014; 50: 66777. DOI: 10.1165/rcmb.2013-0397TR
  72. Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, et al. Association of triglyceride-glucose index and lung health: A population-based study. Chest. 2021; 160: 102634. DOI: 10.1016/j.chest.2021.03.056
  73. Zaigham S, Tanash H, Nilsson PM, Muhammad IF. Triglyceride-Glucose Index is a risk marker of incident COPD events in women. Int J Chron Obstruct Pulmon Dis. 2022; 17: 1393401. DOI: 10.2147/COPD.S360793
  74. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32: 9629. DOI: 10.1183/09031936.00012408
  75. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010; 137: 10917. DOI: 10.1378/chest.09-2029
  76. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr.. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis. 1989; 140: S4955. DOI: 10.1164/ajrccm/140.3_Pt_2.S49
  77. Machado FVC, Pitta F, Hernandes NA, Bertolini GL. Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance. Endocrine. 2018; 61: 1722. DOI: 10.1007/s12020-018-1554-z
DOI: https://doi.org/10.5334/gh.1303 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 11, 2023
Accepted on: Feb 5, 2024
Published on: Feb 23, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Dandan Zheng, Ligong Cao, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.